Skip to main content
Category

Disease Area

BrainCancerCancerDisease AreaLabMedia ReleasesMelanoma DiscoveryMelonomaNews & EventsResearchResearch AreaSystems Biology and Genomics

Lowering cancer drug dose could open tumours to immunotherapy

By | Brain, Cancer, Cancer, Disease Area, Lab, Media Releases, Melanoma Discovery, Melonoma, News & Events, Research, Research Area, Systems Biology and Genomics

Groundbreaking research undertaken at the Harry Perkins Institute of Medical Research in Perth has shown that administering anti-cancer drugs at a hundred-fold lower dose than standard protocols could improve the…

Chronic Kidney DiseaseKidney DiseaseLabMedia ReleasesMolecular Endocrinology and PharmacologyNews & EventsResearchResearch Area

Phase 3 drug trial for rare chronic kidney disease achieves key milestone

By | Chronic Kidney Disease, Kidney Disease, Lab, Media Releases, Molecular Endocrinology and Pharmacology, News & Events, Research, Research Area

Biopharmaceutical company, Dimerix Limited (ASX: DXB, “Dimerix”), which is developing new treatments for types of inflammatory kidney and respiratory diseases, has announced successful interim results of a Phase 3 trial…